CIK 0001167419
- Large accelerated filer
Riot Platforms, Inc.
Sign in to watch- Ticker
- RIOT
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 841553387
- Phone
- +1 303-794-2000
- Business address
- 85 RIO GRANDE DRIVE, SUITE 200, CASTLE ROCK, CO, 80104
- Former names
- Riot Blockchain, Inc., Bioptix, Inc., Venaxis, Inc., AspenBio Pharma, Inc., ASPENBIO INC
- 4 Planned sale CEO sold 100,000 shares at $15.12 ($1,512,000)
- 4 Grant or award Director acquired 16,103 shares (grant or award)
- 4 Grant or award Director acquired 16,103 shares (grant or award)
- 4 Grant or award Director acquired 16,103 shares (grant or award)
- 4 Grant or award Director acquired 16,103 shares (grant or award)
- 4/A Planned sale SVP, CAO sold 3,747 shares at $11.88 ($44,514)
- 4 Open-market sale SVP, CAO sold 3,747 shares at $11.88 ($44,514)
- 4 Shares withheld for taxes SVP, CAO gave up 12,965 shares (to pay taxes)
- 4 Shares withheld for taxes COO gave up 20,345 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 101,610 shares (to pay taxes)
- 4 Option exercise EVP, CFO acquired 124,823 shares (option exercise)
- 4 Option exercise Director acquired 12,000 shares (option exercise)
- 4 Grant or award CDCO acquired 583,430 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 8,384 shares at $7.74 ($64,892)
- 4 Open-market sale Director sold 12,000 shares at $7.70 ($92,400)
- 4 Open-market sale Director sold 61,000 shares at $9.58 ($584,380)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 3 of 30 · 598 filings